Skip to content
Engineering, Medical Health Aged Care

Zapping stem cells could boost growth of new tissues and organs

RMIT University 3 mins read

Scientists in Melbourne have discovered how tiny electrical pulses can steer stem cells as they grow, opening the door to new improved ways of creating new tissues, organs, nerves and bones.

Dr Amy Gelmi, a Senior Lecturer at RMIT University's School of Science, led the work using advanced atomic force microscopy to track how stem cells change their structure when exposed to electrical stimulation.

The study reveals, for the first time, how living stem cells physically respond to external signals in real time – reshaping themselves within minutes and setting off changes that influence what type of cell they eventually become.

“Stem cells are part of us all – even as adults – in our bone and in our fat tissue,” said Gelmi, who is also affiliated with Aikenhead Centre for Medical Discovery (ACMD) at St Vincent’s Hospital in Melbourne.  

“These tiny cells are our own little healing super-power, able to form many different parts of our body – if only we can figure out how to tell them to change.”

One area which the team is working on is understanding how stem cells respond to physical and electrical cues rather than traditional chemicals. This could help researchers create materials that better mimic the body’s natural environment – a critical step towards engineered tissues and organs.

“Most researchers use chemicals to control the development of stem cells – for example, feeding the cells special solutions to make muscle or bone,” Gelmi said.

“This can work – but has its limitations.”

The team’s research focuses now on showing that stem cells do not just react chemically, by showing the cells sensing and responding to tiny electrical signals, co-researcher Dr Peter Sherrell said.

“By controlling those signals precisely, we can start to guide how the cells behave and what they might turn into, whether that’s bone, nerve or muscle tissue,” said Sherrell from the School of Science.

“That’s really promising for tissue engineering and regenerative medicine.”

The research shows that even subtle electrical changes can alter the stiffness and shape of a cell’s internal skeleton, which in turn affects how it develops.

The RMIT team worked with Dr Joseph Berry, from the University of Melbourne, to model how the cells convert physical stimulation into biological responses. Other co-researchers are Kaiwen Zhang, Chayla Reeves and Aaron Elbourne from RMIT’s School of Science and Kate Fox from the School of Engineering.

“By combining the experimental data with computer modelling, we can predict how a cell will respond to different electrical patterns,” Berry said.

“That gives us a roadmap for designing materials or devices that talk to cells in a language they understand.”

Gelmi said the work highlighted how physics and biology are increasingly intertwined in regenerative medicine.

“The future of tissue repair isn’t just about chemistry – it’s about designing materials that can sense, communicate and adapt,” she said.

Next steps for industry and medtech

The research team wants to collaborate with industry partners in biotechnology and medical devices to translate the discovery into practical applications.

Potential uses include:

  • smart implants that use built-in micro-electrodes to encourage bone or nerve regrowth
  • bioreactor systems that use electrical signals to pre-condition stem cells before implantation
  • next-generation materials that adapt dynamically to the body as healing progresses.

“Our improved understanding of how electrical cues drive cell behaviour gives us a foundation to engineer responsive materials,” Gelmi said.

“With the right industry partnerships, that could transform how we approach wound healing, implant integration and even organ regeneration.”

Organisations that want to partner with RMIT researchers can contact [email protected]

The study, ‘Live quantitative characterization for stem cell biomechanics’, was published in Advanced Materials Interfaces (DOI: 10.1002/admi.202500403).


Contact details:

Will Wright and the RMIT media team
RMIT University
m: +61 417 510 735
e: [email protected]
e: [email protected] 

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 13/01/2026
  • 14:06
Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney

Simple tool predicts who is most at risk of dementia after stroke

A new international study led by researchers from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) has developed the first practical, five-year dementia risk…

  • Contains:
  • Business Company News, Medical Health Aged Care
  • 13/01/2026
  • 10:50
Nova Eye Medical (ASX:EYE)

Nova Eye Medical Reports Record Sales Result for December 2025 Quarter

HIGHLIGHTS Record December quarter with global sales of US$6.1 million, up 38% on pcp and 25% on the September 2025 quarter Global six-month sales…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 13/01/2026
  • 10:09
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Reports Clinical Response for StemSmart(TM) Treatment in Fistulising Crohn’s Disease Under Special Access Program

13 January 2026 – Perth, Australia | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has today announced a “Clinical Response” from patients treated with its patented StemSmart™ Mesenchymal Stem Cell (MSC) therapy under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS) for fistulising Crohn’s disease. Three of four patients treated in Cohort 1 of the Special Access Program demonstrated a successful “Clinical Response” following treatment with StemSmart™, with the fourth patient showing a partial response with further clinical assessment needed. A Clinical Response is defined as either closure of at least 50 per cent of fistula openings or a reduction in fistula…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.